임상시험 영상 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

The global demand for Clinical Trial Imaging Market is presumed to reach the market size of nearly USD 4.41 Billion by 2032 from USD 2.19 Billion in 2023 with a CAGR of 8.09% under the study period 2024 - 2032.

Clinical trial imaging involves the use of various imaging techniques, such as MRI, CTs, and PET, to assess and analyze medical conditions or treatment outcomes in clinical trials. These images provide valuable data for researchers and clinicians, aiding in the evaluation of treatment efficacy, disease progression, and patient response.

MARKET DYNAMICS

The clinical trial imaging market is driven by the increasing complexity of clinical trials, advancements in medical imaging technologies, and the demand for objective and quantitative imaging data in drug development. The market experiences growth as pharmaceutical and biotechnology companies seek to enhance the efficiency and accuracy of clinical trials by incorporating imaging endpoints. Imaging technologies allow for non-invasive monitoring of disease progression and treatment response, facilitating early decision-making and reducing the need for invasive procedures. Additionally, regulatory agencies' increasing acceptance of medical imaging as a valuable biomarker in clinical trials contributes to the market's expansion. The rise in precision medicine and the development of targeted therapies further drive the demand for imaging techniques to identify suitable patient populations. The market is also influenced by the adoption of decentralized and virtual clinical trials, where imaging is crucial in remote monitoring and data collection, reflecting the evolving landscape of clinical trial methodologies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of clinical trial imaging. The growth and trends of clinical trial imaging industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the clinical trial imaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service

• Clinical Trial Design And Consultation Services
• Reading And Analytical Services
• Operational Imaging Services
• System And Technology Support Services
• Project And Data Management

By Modality

• Computed Tomography
• Magnetic Resonance Imaging
• X-Ray
• Ultrasound
• Optical Coherence Tomography (OCT)
• Others

By Application

• NASH
• CKD
• Diabetes
• Cardiovascular Diseases
• Ophthalmology
• Musculoskeletal
• Oncology
• Gastroenterology
• Pediatrics
• Others

By End Use

• Biotechnology And Pharmaceutical Companies
• Medical Devices Manufacturers
• Academic And Government Research Institutes
• Contract Research Organizations (CROs)
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trial Imaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trial Imaging market include IXICO plc, Navitas Life Sciences, Resonance Health, ProScan Imaging, Radiant Sage LLC, Medpace, Biomedical Systems Corp, Cardiovascular Imaging Technologies, Intrinsic Imaging, BioTelemetry. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CLINICAL TRIAL IMAGING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Service
  • 3.7.2 Market Attractiveness Analysis By Modality
  • 3.7.3 Market Attractiveness Analysis By Application
  • 3.7.4 Market Attractiveness Analysis By End Use
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY SERVICE

• 5.1 Overview by Service
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Service
• 5.4 Clinical Trial Design And Consultation Services Historic and Forecast Sales by Regions
• 5.5 Reading And Analytical Services Historic and Forecast Sales by Regions
• 5.6 Operational Imaging Services Historic and Forecast Sales by Regions
• 5.7 System And Technology Support Services Historic and Forecast Sales by Regions
• 5.8 Project And Data Management Historic and Forecast Sales by Regions

6 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY MODALITY

• 6.1 Overview by Modality
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Modality
• 6.4 Computed Tomography Historic and Forecast Sales by Regions
• 6.5 Magnetic Resonance Imaging Historic and Forecast Sales by Regions
• 6.6 X-Ray Historic and Forecast Sales by Regions
• 6.7 Ultrasound Historic and Forecast Sales by Regions
• 6.8 Optical Coherence Tomography (OCT) Historic and Forecast Sales by Regions
• 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 NASH Historic and Forecast Sales by Regions
• 7.5 CKD Historic and Forecast Sales by Regions
• 7.6 Diabetes Historic and Forecast Sales by Regions
• 7.7 Cardiovascular Diseases Historic and Forecast Sales by Regions
• 7.8 Ophthalmology Historic and Forecast Sales by Regions
• 7.9 Musculoskeletal Historic and Forecast Sales by Regions
• 7.10. Oncology Historic and Forecast Sales by Regions
• 7.11 Gastroenterology Historic and Forecast Sales by Regions
• 7.12 Pediatrics Historic and Forecast Sales by Regions
• 7.13 Others Historic and Forecast Sales by Regions

8 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY END USE

• 8.1 Overview by End Use
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End Use
• 8.4 Biotechnology And Pharmaceutical Companies Historic and Forecast Sales by Regions
• 8.5 Medical Devices Manufacturers Historic and Forecast Sales by Regions
• 8.6 Academic And Government Research Institutes Historic and Forecast Sales by Regions
• 8.7 Contract Research Organizations (CROs) Historic and Forecast Sales by Regions
• 8.8 Others Historic and Forecast Sales by Regions

9 . GLOBAL CLINICAL TRIAL IMAGING MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. South East Asia Sales Analysis
  • 9.5.10. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIAL IMAGING COMPANIES

• 10.1. Clinical Trial Imaging Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF CLINICAL TRIAL IMAGING INDUSTRY

• 11.1. Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. IXICO plc
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Navitas Life Sciences
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Resonance Health
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. ProScan Imaging
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Radiant Sage LLC
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Medpace
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Biomedical Systems Corp
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Cardiovascular Imaging Technologies
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Intrinsic Imaging
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. BioTelemetry
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies